4109 Stock Overview
Jia Jie Biomedical Co., Ltd. engages in the soft-shelled turtle food processing, manufacturing, sales, and trading business in Taiwan and Mainland China.
Jia Jie Biomedical Co., Ltd. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||NT$15.10|
|52 Week High||NT$16.00|
|52 Week Low||NT$12.35|
|1 Month Change||0.67%|
|3 Month Change||6.71%|
|1 Year Change||17.05%|
|3 Year Change||-24.12%|
|5 Year Change||-28.60%|
|Change since IPO||16.05%|
Recent News & Updates
|4109||TW Personal Products||TW Market|
Return vs Industry: 4109 exceeded the TW Personal Products industry which returned -3.5% over the past year.
Return vs Market: 4109 exceeded the TW Market which returned -18% over the past year.
|4109 Average Weekly Movement||2.2%|
|Personal Products Industry Average Movement||5.7%|
|Market Average Movement||5.1%|
|10% most volatile stocks in TW Market||8.3%|
|10% least volatile stocks in TW Market||2.4%|
Stable Share Price: 4109 is less volatile than 75% of TW stocks over the past 3 months, typically moving +/- 2% a week.
Volatility Over Time: 4109's weekly volatility (2%) has been stable over the past year.
About the Company
Jia Jie Biomedical Co., Ltd. engages in the soft-shelled turtle food processing, manufacturing, sales, and trading business in Taiwan and Mainland China. The company is also involved in the dairy products manufacturing, miscellaneous food manufacturing, such as turtle egg powder capsules, enzyme powder, tortoise ointment, and soft-shelled turtle oil; import and export trade business; and distribution, bidding, quotation, and other businesses. In addition, it engages in the beverage, candy, bakery and supplementary food, and cosmetics wholesale business; water purification equipment and related parts production; and life insurance and product insurance brokerage.
Jia Jie Biomedical Co., Ltd. Fundamentals Summary
|4109 fundamental statistics|
Is 4109 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|4109 income statement (TTM)|
|Cost of Revenue||NT$181.83m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.059|
|Net Profit Margin||1.86%|
How did 4109 perform over the long term?See historical performance and comparison